JAMP-DOCUSATE CALCIUM 240 MG
DOCUSATE CALCIUM : 240 MG · DIN 02283255 · JAMP PHARMA CORPORATION
Health Canada status: DORMANT
What is JAMP-DOCUSATE CALCIUM?
JAMP-DOCUSATE CALCIUM 240 MG contains DOCUSATE CALCIUM : 240 MG. It is listed in the Health Canada Drug Product Database under DIN 02283255, held by JAMP PHARMA CORPORATION, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as dormant, status dated 31-Jul-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02283255 |
|---|---|
| Brand name | JAMP-DOCUSATE CALCIUM |
| Generic / active ingredient | DOCUSATE CALCIUM : 240 MG |
| Manufacturer | JAMP PHARMA CORPORATION |
| Strength | 240 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AA02 DOCUSATE SODIUM |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 31-Jul-2023 |
| Original market date | 2006-10-18 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AA02 DOCUSATE SODIUM. 16 of 101 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| COLACE | 10 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | DIN 02090163 |
| COLACE CAPSULES | 100 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 02106256 |
| COLACE CLEAR | 100 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 02484226 |
| COLACE SYRUP | 20 MG / 5 ML | SYRUP | PHARMASCIENCE INC | MARKETED | DIN 02086018 |
| DOCUSATE SODIUM | 100 MG | CAPSULE | SANIS HEALTH INC | MARKETED | DIN 02426838 |
| M-DOCUSATE SODIUM 100 MG | 100 MG | CAPSULE | MANTRA PHARMA INC | MARKETED | DIN 02437317 |
| PMS-DOCUSATE SODIUM | 100 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 00703494 |
| RATIO-DOCUSATE SODIUM | 20 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | DIN 00870226 |
| SELAX CAP 100MG | 100 MG | CAPSULE | ODAN LABORATORIES LTD | MARKETED | DIN 00514888 |
| SIROP DOCUSATE DE SODIUM U.S.P. 4MG/ML | 20 MG / 5 ML | SYRUP | LABORATOIRE ATLAS INC | MARKETED | DIN 02238283 |
Who else supplies DOCUSATE SODIUM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DOCUSATE SODIUM appears in 700 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.